These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 16619517
21. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells. Song JH, Song DK, Herlyn M, Petruk KC, Hao C. Clin Cancer Res; 2003 Sep 15; 9(11):4255-66. PubMed ID: 14519653 [Abstract] [Full Text] [Related]
22. JNK/SAPK activity contributes to TRAIL-induced apoptosis. Herr I, Wilhelm D, Meyer E, Jeremias I, Angel P, Debatin KM. Cell Death Differ; 1999 Feb 15; 6(2):130-5. PubMed ID: 10200559 [Abstract] [Full Text] [Related]
23. Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells. Lacour S, Micheau O, Hammann A, Drouineaud V, Tschopp J, Solary E, Dimanche-Boitrel MT. Oncogene; 2003 Mar 27; 22(12):1807-16. PubMed ID: 12660816 [Abstract] [Full Text] [Related]
24. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW, Shah S. Asia Pac J Clin Nutr; 2005 Mar 27; 14(4):366-73. PubMed ID: 16326643 [Abstract] [Full Text] [Related]
27. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Toyota H, Kondo S, Kyo S, Mizuguchi J. Anticancer Res; 2006 Mar 27; 26(1A):99-105. PubMed ID: 16475685 [Abstract] [Full Text] [Related]
28. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA. Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726 [Abstract] [Full Text] [Related]
29. Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. Xu J, Zhou JY, Wu GS. Cancer Res; 2006 Oct 15; 66(20):10092-9. PubMed ID: 17047073 [Abstract] [Full Text] [Related]
30. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Jin H, Yang R, Fong S, Totpal K, Lawrence D, Zheng Z, Ross J, Koeppen H, Schwall R, Ashkenazi A. Cancer Res; 2004 Jul 15; 64(14):4900-5. PubMed ID: 15256461 [Abstract] [Full Text] [Related]
31. Protective effects of estradiol on TRAIL-induced apoptosis in a human oligodendrocytic cell line: evidence for multiple sites of interactions. Cantarella G, Risuglia N, Lombardo G, Lempereur L, Nicoletti F, Memo M, Bernardini R. Cell Death Differ; 2004 May 15; 11(5):503-11. PubMed ID: 14739940 [Abstract] [Full Text] [Related]
32. c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells. Takada E, Hata K, Mizuguchi J. Cancer Chemother Pharmacol; 2008 Sep 15; 62(4):569-76. PubMed ID: 18026729 [Abstract] [Full Text] [Related]
33. TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway. Jurewicz A, Matysiak M, Andrzejak S, Selmaj K. Glia; 2006 Jan 15; 53(2):158-66. PubMed ID: 16206163 [Abstract] [Full Text] [Related]
34. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents. Sun J, Fu ZM, Fang CQ, Li JH. Chin Med J (Engl); 2007 Mar 05; 120(5):400-4. PubMed ID: 17376311 [Abstract] [Full Text] [Related]
35. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D. FEBS J; 2008 Apr 05; 275(8):1925-36. PubMed ID: 18341587 [Abstract] [Full Text] [Related]
36. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. Gao X, Deeb D, Jiang H, Liu YB, Dulchavsky SA, Gautam SC. J Exp Ther Oncol; 2005 Apr 05; 5(1):39-48. PubMed ID: 16416600 [Abstract] [Full Text] [Related]
37. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H, Bamberg M, Schulze-Osthoff K, Budach W. Oncogene; 2001 Apr 19; 20(17):2190-6. PubMed ID: 11360204 [Abstract] [Full Text] [Related]
38. Lipopolysaccharides-activated human astroglioma cells induce apoptotic death of T-lymphocytes via c-Jun N-terminal kinases-dependent up-regulation of TRAIL. Kwon D, Cheong JH, Lee JC, Kwon JH, Kim WK. Neurosci Res; 2006 Apr 19; 54(4):338-43. PubMed ID: 16442178 [Abstract] [Full Text] [Related]
39. Ionizing radiation utilizes c-Jun N-terminal kinase for amplification of mitochondrial apoptotic cell death in human cervical cancer cells. Kim MJ, Lee KH, Lee SJ. FEBS J; 2008 May 19; 275(9):2096-108. PubMed ID: 18373696 [Abstract] [Full Text] [Related]
40. Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line. Sarker M, Ruiz-Ruiz C, López-Rivas A. Cell Death Differ; 2001 Feb 19; 8(2):172-81. PubMed ID: 11313719 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]